GenScript Launches GenEZ™ Next-Generation Molecular Cloning Service


Posted April 8, 2014 by lorrainegenscript

GenScript, the world’s largest provider of synthetic genes, has launched a new GenEZ™ Next-Generation Molecular Cloning service, which reduces the hands-on time that researchers spend on cloning to less than 30 minutes.

 
GenScript, the world's largest provider of synthetic genes, has launched a new GenEZ™ Next-Generation Molecular Cloning service, which reduces the hands-on time that researchers spend on cloning to less than 30 minutes.

GenEZ™ leverages GenScript's decade of experience as the leading gene synthesis supplier in the US to usher in a new era of molecular cloning. The GenEZ™ Next-Generation Molecular Cloning service bundles gene synthesis of any insert sequence up to 3kb with cloning into popular commercial vectors of customers' choice, all with convenient per-clone pricing, starting at $299/clone.

In addition, online ordering of GenEZ™ molecular cloning is as easy as 1, 2, 3: simply specify the gene insert sequence and desired vector, mail in the vector, and receive 10μg plasmid DNA accompanied by sequence chromatograms.

"With GenEZ™ molecular cloning service, scientists are freed up to focus on their research instead of being bogged down by routine molecular cloning work" said Jeffrey Hung, Ph.D., VP of Service Marketing. "The life scientists that we talked to are excited because the GenEZ™ molecular cloning service will save both money and time for them."

Molecular cloning typically takes 12 hours or more of hands-on time over several days or weeks, consumes numerous expensive reagents, and often requires time-consuming troubleshooting to get the desired clones. GenEZ™ guarantees successful outcome and on-time delivery of your desired clones, extending GenScript's longstanding commitment to providing 100% sequence fidelity and research-ready deliverables.

About GenScript

GenScript is the leading gene, peptide, protein and antibody research partner for fundamental life science research, translational biomedical research, and early stage pharmaceutical development. Since our establishment in 2002, GenScript has exponentially grown to become a global leading Contract Research Organization that provide services and products to scientists in 86 countries worldwide. GenScript built the best-in-class capacity and capability for biological research services encompassing gene synthesis and molecular biology, peptide synthesis, custom antibodies, protein expression, antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to Make Research Easy.

To learn more about GenEZ™ Next-Generation Molecular Cloning, visit http://www.genscript.com/genez_next_gen_cloning.html today or contact your local customer service representative.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By lorraine xu
Country United States
Categories Health
Tags genez nextgeneration molecular cloning service , genscript
Last Updated April 8, 2014